Recent advances in behavioural genetics have substantially reshaped our understanding of psychiatric disorders. Large-scale genome-wide association studies indicate that genetic differences account for a significant proportion of variation in psychiatric conditions, including schizophrenia, bipolar disorder, major depressive disorder and attention-deficit/hyperactivity disorder. Importantly, these findings do not suggest the existence of single “disease genes”, but rather the cumulative influence of thousands of genetic variants, each contributing a small effect.
Heritability estimates for many psychiatric disorders are often in the region of 40–60 per cent. However, heritability does not imply determinism. Genetic influence is probabilistic rather than predictive at the level of the individual. A higher genetic liability increases statistical risk, but it does not determine outcome. Environmental exposures, developmental timing, and stochastic biological processes continue to play critical roles.
One of the most significant methodological developments in recent years has been the emergence of polygenic scores. These aggregate measures summarise the combined effect of numerous genetic variants associated with a given trait or disorder. While current polygenic scores explain only a modest proportion of variance in most psychiatric conditions, they demonstrate that genetic liability can be quantified at population level. As datasets expand and analytical methods improve, their predictive utility may increase, although ethical and practical considerations remain substantial.
Behavioural genetics has also clarified the distinction between shared and non-shared environmental influences. Many environmental factors previously assumed to operate at family level may in fact reflect genetically mediated processes. This challenges simplistic environmental explanations and highlights the complexity of gene–environment interplay. Genetic factors can influence the environments individuals select, evoke or experience — a process sometimes referred to as gene–environment correlation.
For clinicians, the relevance of these developments lies not in genetic reductionism, but in nuance. A developmentally informed, probabilistic understanding of risk may refine formulation and encourage greater sensitivity to heterogeneity within diagnostic categories. At present, genomic data do not provide deterministic diagnostic tools, but they do contribute to a more sophisticated model of psychiatric vulnerability.
Modern behavioural genetics therefore invites clinicians to move beyond binary nature-versus-nurture frameworks. Psychiatric disorders emerge from dynamic interactions between biological predisposition and lived experience across developmental time. The challenge for clinical practice is to integrate emerging genomic knowledge without losing sight of psychological, relational and social complexity.
by Miguel Mealha Estrada
For further discussion on the genetic architecture of ADHD, see my recent article on rare genetic variants and ADHD.
Leave a Reply